Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Riboflavin intake and 5-year blood pressure change in Chinese adults: interaction with hypertensive medication.

Shi Z, Yuan B, Taylor AW, Zhen S, Zuo H, Dai Y, Wittert GA.

Food Nutr Bull. 2014 Mar;35(1):33-42.

PMID:
24791577
2.

Inadequate riboflavin intake and anemia risk in a Chinese population: five-year follow up of the Jiangsu Nutrition Study.

Shi Z, Zhen S, Wittert GA, Yuan B, Zuo H, Taylor AW.

PLoS One. 2014 Feb 12;9(2):e88862. doi: 10.1371/journal.pone.0088862. eCollection 2014.

3.

Tea consumption is inversely related to 5-year blood pressure change among adults in Jiangsu, China: a cross-sectional study.

Tong X, Taylor AW, Giles L, Wittert GA, Shi Z.

Nutr J. 2014 Oct 14;13:98. doi: 10.1186/1475-2891-13-98.

4.

Blood pressure effects of antihypertensive drugs and changes in lifestyle in a Brazilian hypertensive cohort.

Fuchs FD, Gus M, Moreira WD, Moreira LB, Moraes RS, Rosito GA, Sorucco A, Atanázio P, Machado R.

J Hypertens. 1997 Jul;15(7):783-92.

PMID:
9222947
5.

Pulse pressure is the best predictor of future left ventricular mass and change in left ventricular mass: 10 years of follow-up.

Jokiniitty JM, Majahalme SK, Kähönen MA, Tuomisto MT, Turjanmaa VM.

J Hypertens. 2001 Nov;19(11):2047-54.

PMID:
11677371
6.

Body mass index, blood pressure, diabetes and the risk of anti-hypertensive drug treatment: 12-year follow-up of middle-aged people in eastern Finland.

Jousilahti P, Tuomilehto J, Vartiainen E, Valle T, Nissinen A.

J Hum Hypertens. 1995 Oct;9(10):847-54.

PMID:
8576902
7.

Determinants of blood pressure treatment and control in obese people: evidence from the general population.

Czernichow S, Castetbon K, Salanave B, Vernay M, Barry Y, Batty GD, Hercberg S, Blacher J.

J Hypertens. 2012 Dec;30(12):2338-44. doi: 10.1097/HJH.0b013e3283593010.

PMID:
23032140
8.

Prediction of blood pressure level and need for antihypertensive medication: 10 years of follow-up.

Jokiniitty JM, Majahalme SK, Kähönen MA, Tuomisto MT, Turjanmaa VM.

J Hypertens. 2001 Jul;19(7):1193-201.

PMID:
11446708
9.

Differential control of systolic and diastolic blood pressure : factors associated with lack of blood pressure control in the community.

Lloyd-Jones DM, Evans JC, Larson MG, O'Donnell CJ, Roccella EJ, Levy D.

Hypertension. 2000 Oct;36(4):594-9.

10.

Vital signs: prevalence, treatment, and control of hypertension--United States, 1999-2002 and 2005-2008.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 Feb 4;60(4):103-8.

11.

[Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].

Qiu YG, Yao XY, Tao QM, Zheng P, Chen JZ, Zhu JH, Zhang FR, Zheng LR, Zhao LL.

Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Aug;25(8):710-4. Chinese.

PMID:
15555399
12.
13.

[Blood pressure control in Spanish hypertensive patients in Primary Health Care Centres. PRESCAP 2002 Study].

Llisterri Caro JL, Rodríguez Roca GC, Alonso Moreno FJ, Lou Arnal S, Divisón Garrote JA, Santos Rodríguez JA, Raber Béjar A, de Castellar Sansó R, Ruilope Urioste LM, Banegas Banegas JR; Grupo de Trabajo de Hipertension Arterial de la Sociedad Española de Medicina Rural y Generalista (Grupo HTA/SEMERGEN); Investigadores del Estudio PRESCAP 2002.

Med Clin (Barc). 2004 Feb 14;122(5):165-71. Spanish.

PMID:
14998450
14.
15.

Blood pressure in treated hypertensive individuals with the MTHFR 677TT genotype is responsive to intervention with riboflavin: findings of a targeted randomized trial.

Wilson CP, McNulty H, Ward M, Strain JJ, Trouton TG, Hoeft BA, Weber P, Roos FF, Horigan G, McAnena L, Scott JM.

Hypertension. 2013 Jun;61(6):1302-8. doi: 10.1161/HYPERTENSIONAHA.111.01047. Epub 2013 Apr 22.

16.

Eprosartan-based hypertension therapy, systolic arterial blood pressure and cognitive function: analysis of Middle East data from the OSCAR study.

Radaideh GA, Choueiry P, Ismail A, Eid E, Berrou JP, Sedefdjian A, Sévenier F, Pathak A.

Vasc Health Risk Manag. 2011;7:491-5. doi: 10.2147/VHRM.S19699. Epub 2011 Aug 1.

17.
18.

Riboflavin offers a targeted strategy for managing hypertension in patients with the MTHFR 677TT genotype: a 4-y follow-up.

Wilson CP, Ward M, McNulty H, Strain JJ, Trouton TG, Horigan G, Purvis J, Scott JM.

Am J Clin Nutr. 2012 Mar;95(3):766-72. doi: 10.3945/ajcn.111.026245. Epub 2012 Jan 25.

19.

Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort.

Dufouil C, de Kersaint-Gilly A, Besançon V, Levy C, Auffray E, Brunnereau L, Alpérovitch A, Tzourio C.

Neurology. 2001 Apr 10;56(7):921-6.

PMID:
11294930
20.

Effects of antihypertensive therapy on blood pressure and left ventricular hypertrophy in patients with severe hypertension.

Sumino H, Nakamura T, Kanda T, Sakamaki T, Sato K, Saito Y, Hoshino J, Kurashina T, Ono Z, Takahashi T, Ichikawa S, Kurabayashi M, Nagai R.

Jpn Heart J. 2000 May;41(3):339-48.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk